1. 14-3-3E, a new alarmin candidate, elicits a catabolic and proinflammatory effect involving innate immunity through TLR signaling in osteoarthritis. (April 2019) Authors: Millerand, M.; Sudre, L.; Nefla, M.; Pene, F.; Rousseau, C.; Ravat, A.; Pons, A.; Andre-Leroux, G.; Berenbaum, F.; Jacques, C. Journal: Osteoarthritis and cartilage Issue: Volume 27(2019)Supplement 1 Page Start: S375 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OC-0538: Daily versus weekly prostate cancer image-guided radiotherapy: A Phase 3 randomized trial. (April 2018) Authors: De Crevoisier, R.; Bayar, M.; Pommier, P.; Muracciole, X.; Pene, F.; Dudouet, P.; Latorzeff, I.; Beckendorf, V.; Bachaud, J.; Supiot, S.; Chauvet, B.; Laplanche, A.; Bossi, A.; Nguyen, T.; Crehange, G.; Lagrange, J. Journal: Radiotherapy and oncology Issue: Volume 127(2018)Supplement 1 Page Start: S287 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗